USFDA
Experiencing hot flashes and night sweats due to menopause? FDA approves new hormone-free drug
Lynkuet is an FDA-approved, hormone-free pill designed to relieve hot flashes for women in menopause. Set to launch in November 2025, it may help reduce menopause symptoms without hormonal therapy.
3 min read28 Oct 2025Coca-Cola recall: Thousands of Coke, Sprite cans found contaminated, likely to cause health issues
The FDA recalled Coca-Cola Zero Sugar, Coca-Cola and Sprite due to potential metal contamination, affecting over 70,000 cans. Consumers are advised to stay cautious as the recall may expand.
1 min read24 Oct 2025Cinnamon recall alert: FDA finds high lead levels in 16 brands, asks US consumers to stop use immediately
The FDA has recalled 16 ground cinnamon brands across the US due to high lead levels, warning consumers of serious health risks, especially during the festive season.
2 min read17 Oct 2025Public Health Alert: FDA recalls HAETAE and Roshni cinnamon over dangerous lead levels — ‘Throw away’
The FDA added HAETAE-brand and Roshni-brand ground cinnamon to its “Public Health Alert” list due to high levels of lead.
1 min read15 Oct 2025Big catch: India wins US nod for seafood exports; rivals China, Mexico face ban
India exported seafood worth $7.39 billion in FY25, of which more than a third or $2.68 billion went to the US. Indian shrimp exports to the US are currently less competitive than those from Ecuador, Vietnam, and Indonesia due to the steep 50% tariff.
3 min read9 Oct 2025Vinay Prasad is a Bernie Sanders acolyte in MAHA drag
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.
4 min read28 Jul 2025Sun Pharma launches alopecia drug Leqselvi in US after settling patent dispute
Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval, Incyte Corporation filed a patent infringement lawsuit against Sun Pharma, alleging that Leqselvi infringed upon its existing patents.
2 min read14 Jul 2025Wockhardt exits its US generics business
As part of the strategic realignment of its US business, the company has filed for voluntary liquidation under Chapter 7 of the US Bankruptcy Code for its US step down subsidiaries, Morton Grove Pharmaceuticals Inc. and Wockhardt USA LLC.
1 min read11 Jul 2025Alembic Pharma surges over 12% on USFDA approval for Cancer drug
Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injection. This milestone adds to its growing US generics portfolio and supports financial performance, with a reported 14% increase in net profit.
2 min read30 Jun 2025Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.